000 01672 a2200493 4500
005 20250515090819.0
264 0 _c20080826
008 200808s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/s00280-007-0601-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBernardi, Ronald J
245 0 0 _aPhase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_cJul 2008
300 _a355-61 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntimetabolites, Antineoplastic
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aDeoxycytidine
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInjections, Spinal
650 0 4 _aMale
650 0 4 _aMeningeal Neoplasms
_xblood
650 0 4 _aMiddle Aged
650 0 4 _aGemcitabine
700 1 _aBomgaars, Lisa
700 1 _aFox, Elizabeth
700 1 _aBalis, Frank M
700 1 _aEgorin, Merrill J
700 1 _aLagattuta, Theodore F
700 1 _aAikin, Alberta
700 1 _aWhitcomb, Patricia
700 1 _aRenbarger, Jamie
700 1 _aLieberman, Frank S
700 1 _aBerg, Stacey L
700 1 _aBlaney, Susan M
773 0 _tCancer chemotherapy and pharmacology
_gvol. 62
_gno. 2
_gp. 355-61
856 4 0 _uhttps://doi.org/10.1007/s00280-007-0601-x
_zAvailable from publisher's website
999 _c17431489
_d17431489